Inventor · disambiguated record
Rajesham Boge
Also filed as: BOGE RAJESHAM
9 granted patents·8 pending applications·19 citations·filing 2011–2022
82Inventor score
Files withDr Reddys Laboratories Ltd5MSN LABORATORIES PRIVATE LTD3REDDYS LAB LTD DR3BIOPHORE INDIA PHARMACEUTICALS PVT LTD2KANNIAH SUNDRA LAKSHMI1
Top patents by PatentIndex Score
17 records- 0188US11261160B2Process for the preparation of N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide, (2S)-hydroxybutanedioate and its polymorphs thereofMSN LABORATORIES PRIVATE LTD R&D CENTER·Filed 2017·Granted Mar 1, 2022·9 cites·15 claims
- 0283US10550107B2Process for the preparation of N-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-(2E)-2-butenamide (2Z)-2-butenedioate (1:2) and its polymorphs thereofMSN LABORATORIES PRIVATE LTD·Filed 2016·Granted Feb 4, 2020·3 cites·20 claims
- 0381US9701641B2Enzalutamide polymorphic forms and its preparationDr Reddys Laboratories Ltd·Filed 2016·Granted Jul 11, 2017·3 cites·5 claims
- 0469US10011590B2Crystalline forms of vilazodone hydrochloride and vilazodone free baseDr Reddys Laboratories Ltd·Filed 2017·Granted Jul 3, 2018·1 cites·5 claims
- 0566US9283210B2Amorphous mirabegron and processes for crystal forms of mirabegronPEDDY VISHWESHWAR·Filed 2012·Granted Mar 15, 2016·2 cites·11 claims
- 0660US9655885B2Amorphous mirabegron and processes for crystal forms of mirabegronDr Reddys Laboratories Ltd·Filed 2015·Granted May 23, 2017·1 cites·11 claims
- 0760US2025059145A1Solid forms of 1-{3-[3-(4-chlorophenyl) propoxy] propyl} piperidine hydrochloride and process for the preparation thereofBIOPHORE INDIA PHARMACEUTICALS PVT LTD·Filed 2022·Application pending·0 cites
- 0859US2015239848A1Enzalutamide polymorphic forms and its preparationREDDYS LAB LTD DR·Filed 2013·Application pending·0 cites
- 0953US2017267645A1Enzalutamide polymorphic forms and its preparationDr Reddys Laboratories Ltd·Filed 2017·Application pending·0 cites
- 1051US2019002444A1Crystalline forms of vilazodone hydrochloride and vilazodone free baseDr Reddys Laboratories Ltd·Filed 2018·Application pending·0 cites
- 1150US2015126525A1Crystalline forms of vilazodone hydrochloride and vilazodone free baseREDDYS LAB LTD DR·Filed 2013·Application pending·0 cites
- 1247US2014187538A1Lorcaserin hydrochlorideREDDYS LAB LTD DR·Filed 2013·Application pending·0 cites
- 1346US2019160005A1Method of Preparing Solid Dispersions of Active Pharmaceutical IngredientsBIOPHORE INDIA PHARMACEUTICALS PVT LTD·Filed 2018·Application pending·0 cites
- 1440US10913762B2Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereofMSN LABORATORIES PRIVATE LTD·Filed 2017·Granted Feb 9, 2021·0 cites·17 claims
- 1535US9212172B2Preparation of crystalline bazedoxifene and its saltsKANNIAH SUNDRA LAKSHMI·Filed 2011·Granted Dec 15, 2015·0 cites·24 claims
- 1633US10703731B2Process for the preparation of Trisodium (4- {[1S,3R)-1-([1,1′-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino}-4-oxobutanoate)-(N-petanoyl-N-{[2′-(1H-tetrazol-1-1D-5-yl)[1,1′-biphenyl]-4-yl]methyl}- L-valinate) and its polymorphs thereofMSN LABORATORIES PRIVATE LTD·Filed 2017·Granted Jul 7, 2020·0 cites·12 claims
- 1731US2019177281A1Process for the preparation of 5-[[[(2s)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl] [(1s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl]amino] methyl-2-methoxybenzoic acid and its polymorphs thereofTHIRUMALAI RAJAN SROMOVASAM·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →